BiotechSino develops single B cell technology CellProbe™ and next-generation sequencing analysis of
antibody repertoires CellSeq™ to isolate the elite antibody from patients who have overcome disease.

BiotechSino's CellProbe™ and CellSeq™ platform uses donor B cells or cultured plasma cells obtained 
from blood or lymphoid organs.